{"protocolSection":{"identificationModule":{"nctId":"NCT06479122","orgStudyIdInfo":{"id":"2405-052-1535"},"organization":{"fullName":"Seoul National University Hospital","class":"OTHER"},"briefTitle":"Efficacy of Acetaminophen Alone Versus Combination of Acetaminophen/Ibuprofen After Cesarean Section","officialTitle":"Efficacy of Intravenous Acetaminophen Alone Versus Combination of Acetaminophen/Ibuprofen (Maxigesic速IV) in Multimodal Analgesia After Cesarean Section: a Randomized Controlled Trial"},"statusModule":{"statusVerifiedDate":"2024-06","overallStatus":"NOT_YET_RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2024-06-25","type":"ESTIMATED"},"primaryCompletionDateStruct":{"date":"2025-06-25","type":"ESTIMATED"},"completionDateStruct":{"date":"2025-08-25","type":"ESTIMATED"},"studyFirstSubmitDate":"2024-06-18","studyFirstSubmitQcDate":"2024-06-24","studyFirstPostDateStruct":{"date":"2024-06-28","type":"ACTUAL"},"lastUpdateSubmitDate":"2024-06-27","lastUpdatePostDateStruct":{"date":"2024-07-01","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Jeong-Hwa Seo","investigatorTitle":"Professor","investigatorAffiliation":"Seoul National University Hospital"},"leadSponsor":{"name":"Seoul National University Hospital","class":"OTHER"}},"oversightModule":{"oversightHasDmc":true,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"The investigators aim to compare the analgesic efficacy of intravenous acetaminophen alone versus combination of acetaminophen/ibuprofen (Maxigesic速IV) in multimodal analgesia after cesarean section."},"conditionsModule":{"conditions":["Cesarean Section","Postoperative Pain"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE4"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"TRIPLE","whoMasked":["PARTICIPANT","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":84,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Acetaminophen","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Acetaminophen"]},{"label":"Acetaminophen/Ibuprofen","type":"EXPERIMENTAL","interventionNames":["Drug: Acetaminophen/Ibuprofen"]}],"interventions":[{"type":"DRUG","name":"Acetaminophen","description":"1g acetaminophen is administered during skin closure (end of operation).","armGroupLabels":["Acetaminophen"],"otherNames":["Acetaminophen #1"]},{"type":"DRUG","name":"Acetaminophen/Ibuprofen","description":"A mixture of 1g acetaminophen and 300 mg ibuprofen (Maxigesic速IV) is administered during skin closure (end of operation)","armGroupLabels":["Acetaminophen/Ibuprofen"],"otherNames":["Acetaminophen/Ibuprofen #1"]},{"type":"DRUG","name":"Acetaminophen","description":"1g acetaminophen is administered 6 hours after the first administration.","armGroupLabels":["Acetaminophen"],"otherNames":["Acetaminophen #2"]},{"type":"DRUG","name":"Acetaminophen/Ibuprofen","description":"A mixture of 1g acetaminophen and 300 mg ibuprofen (Maxigesic速IV) is administered 6 hours after the first administration.","armGroupLabels":["Acetaminophen/Ibuprofen"],"otherNames":["Acetaminophen/Ibuprofen #2"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Obstetric QoR-11K score 24 hours after end of surgery","description":"Minimum 0, poor recovery; maximum 110, good recovery","timeFrame":"24 hours after end of surgery"}],"secondaryOutcomes":[{"measure":"Numeric rating scale pain score (0-10) 4 hours after end of surgery","description":"0, no pain; 10, worst pain imaginable","timeFrame":"4 hours after end of surgery"},{"measure":"Numeric rating scale pain score (0-10) 8 hours after end of surgery","description":"0, no pain; 10, worst pain imaginable","timeFrame":"8 hours after end of surgery"},{"measure":"Numeric rating scale pain score (0-10) 12 hours after end of surgery","description":"0, no pain; 10, worst pain imaginable","timeFrame":"12 hours after end of surgery"},{"measure":"Numeric rating scale pain score (0-10) 24 h after end of surgery","timeFrame":"24 h after end of surgery"},{"measure":"Numeric rating scale pain score (0-10) 48 hours after end of surgery","description":"0, no pain; 10, worst pain imaginable","timeFrame":"48 hours after end of surgery"},{"measure":"Use of patient-controlled analgesia (FTN, micrograms) during the first 24 hours after end of surgery","timeFrame":"24 h after end of surgery"},{"measure":"Use of patient-controlled analgesia (FTN, micrograms) during the first 48 hours after end of surgery","timeFrame":"48 h after end of surgery"},{"measure":"Use of rescue analgesia during the first 24 hours after end of surgery","timeFrame":"24 h after end of surgery"},{"measure":"Use of rescue analgesia during the first 48 hours after end of surgery","timeFrame":"48 h after end of surgery"},{"measure":"Wound-related complications during hospital stay, up to 5 days","timeFrame":"From end of surgery to patient discharge, up to 5 days"},{"measure":"Operation time","timeFrame":"Duration of operation"},{"measure":"Anesthesia time","timeFrame":"Duration of anesthesia"},{"measure":"Injection level of intrathecal drug","timeFrame":"After arrival at the operating room"},{"measure":"Dosage of intrathecal drug (mg, bupivacaine)","timeFrame":"After arrival at the operating room"},{"measure":"Sensory blockade level by time point","timeFrame":"0, 5, 10 minutes after intrathecal injection and at the end of operation"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients scheduled for elective cesarean section\n* Gestational age \\> 37+0 weeks\n\nExclusion Criteria:\n\n* Emergency cesarean section\n* Multiple pregnancy (e.g. twins, triplets)\n* Body weight \\< 50 kg\n* Preeclampsia\n* History of hypersensitivity to acetaminophen or ibuprofen\n* History of upper gastrointestinal tract bleeding or gastric ulcer\n* Underlying liver disease\n* Underlying kidney disease or GFR \\< 90 mL/min/1.73m2\n* Heart failure or severe hypertension\n* History of asthma\n* Chronic use of barbital or tricyclic antidepressants","healthyVolunteers":true,"sex":"FEMALE","minimumAge":"19 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Hansol Kim, MD","role":"CONTACT","phone":"+82-10-3160-1548","email":"hansolfrkr@gmail.com"},{"name":"Junghwa Seo, MD, PhD","role":"CONTACT"}]},"ipdSharingStatementModule":{"ipdSharing":"UNDECIDED"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-07-01"},"conditionBrowseModule":{"meshes":[{"id":"D000010149","term":"Pain, Postoperative"}],"ancestors":[{"id":"D000011183","term":"Postoperative Complications"},{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000010146","term":"Pain"},{"id":"D000009461","term":"Neurologic Manifestations"}],"browseLeaves":[{"id":"M13069","name":"Pain, Postoperative","asFound":"Postoperative Pain","relevance":"HIGH"},{"id":"M13066","name":"Pain","relevance":"LOW"},{"id":"M14065","name":"Postoperative Complications","relevance":"LOW"},{"id":"M12404","name":"Neurologic Manifestations","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC10","name":"Nervous System Diseases"}]},"interventionBrowseModule":{"meshes":[{"id":"D000000082","term":"Acetaminophen"},{"id":"D000007052","term":"Ibuprofen"}],"ancestors":[{"id":"D000018712","term":"Analgesics, Non-Narcotic"},{"id":"D000000700","term":"Analgesics"},{"id":"D000018689","term":"Sensory System Agents"},{"id":"D000018373","term":"Peripheral Nervous System Agents"},{"id":"D000045505","term":"Physiological Effects of Drugs"},{"id":"D000058633","term":"Antipyretics"},{"id":"D000000894","term":"Anti-Inflammatory Agents, Non-Steroidal"},{"id":"D000000893","term":"Anti-Inflammatory Agents"},{"id":"D000018501","term":"Antirheumatic Agents"},{"id":"D000016861","term":"Cyclooxygenase Inhibitors"},{"id":"D000004791","term":"Enzyme Inhibitors"},{"id":"D000045504","term":"Molecular Mechanisms of Pharmacological Action"}],"browseLeaves":[{"id":"M2340","name":"Acetaminophen","asFound":"Pilot Study","relevance":"HIGH"},{"id":"M10102","name":"Ibuprofen","asFound":"Last","relevance":"HIGH"},{"id":"M4032","name":"Analgesics","relevance":"LOW"},{"id":"M20786","name":"Analgesics, Non-Narcotic","relevance":"LOW"},{"id":"M29176","name":"Antipyretics","relevance":"LOW"},{"id":"M4218","name":"Anti-Inflammatory Agents, Non-Steroidal","relevance":"LOW"},{"id":"M4217","name":"Anti-Inflammatory Agents","relevance":"LOW"},{"id":"M20604","name":"Antirheumatic Agents","relevance":"LOW"},{"id":"M19209","name":"Cyclooxygenase Inhibitors","relevance":"LOW"},{"id":"M7951","name":"Enzyme Inhibitors","relevance":"LOW"}],"browseBranches":[{"abbrev":"Antipy","name":"Antipyretics"},{"abbrev":"Analg","name":"Analgesics"},{"abbrev":"All","name":"All Drugs and Chemicals"},{"abbrev":"Infl","name":"Anti-Inflammatory Agents"},{"abbrev":"ARhu","name":"Antirheumatic Agents"}]}},"hasResults":false}